Antitumor Effect of Skin of Venenum Bufonis in a NCI-H460 Tumor Regression Model
Authors:
- Tae-Young JeongTJTae-Young Jeong
- Chong Kwan ChoCCChong Kwan Cho
- Yeon-Weol LeeYLYeon-Weol Lee
- Hwa Seung YooHYHwa Seung Yoo
Open Access
- 1 September 2010
- journal article
- Published by Medical Association of Pharmacopuncture Institute in Journal of Acupuncture and Meridian Studies
- Vol. 3 (3) , 181-187
Abstract
This experimental study was performed to investigate the antitumor effect of skin of venenum bufonis (SVB) in NCI-H460 human lung cancer cell xenografted nude mice. NCI-H460 cell lines were cultured and then xenografted into nude mice. Mice were divided into four groups: SVB (0.25 mg/kg) given orally, SVB (0.25 mg/kg) interperitoneally, SVB (0.5 mg/kg) interperitoneally, and the untreated group. Mice were raised and treated for 28 days. Body weight and tumor weight and volumes were measured daily. Absolute organ weight, microhistological observations and biochemical blood analyses were performed on the final day of the study following the sacrificing of these animals. Tumor inhibition rate, mean survival time and percent increase in life span were also calculated. Tumor size decreased in all SVB treated mice. Increasing the dose of SVB attenuated the inhibition rate seen on the 11th day of this experiment. Furthermore, tumor weight and volume in the mice treated with the highest dose of SVB were the smallest. Mice treated with high-dose intraperitoneal SVB gained weight and had significantly smaller spleens compared with untreated mice. Mean survival time and percent increase in life span in the low-dose intraperitoneal SVB treatment group were higher than those of other groups. Biochemical blood analysis revealed that phosphatase and urea nitrogen levels were decreased significantly in 0.25 mg/kg SVB orally treated mice (p < 0.01). Blood level calcium and alanine transaminase significantly decreased with intraperitoneal SVB 0.5 mg/kg (p < 0.05). The findings of this in vivo study suggest that SVB may have potential as a tumor growth inhibitor. Further research that overcomes the limitations of this study to determine the antitumor mechanism of SVB is still required.Keywords
This publication has 10 references indexed in Scilit:
- Apoptosis Induction of Human Lung Carcinoma Cells by Chan Su (Venenum Bufonis) Through Activation of CaspasesJournal of Acupuncture and Meridian Studies, 2009
- Involvement of Caspase-3 Activity and Survivin Downregulation in Cinobufocini-Induced Apoptosis in A 549 CellsExperimental Biology and Medicine, 2009
- PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cellsAnti-Cancer Drugs, 2009
- Membrane dielectric responses of bufalin-induced apoptosis in HL-60 cells detected by an electrorotation chipBiotechnology Letters, 2007
- Antiproliferative, cytotoxic and apoptogenic activity of Indian toad (Bufo melanostictus, Schneider) skin extract on U937 and K562 cellsToxicon, 2006
- Tiam1 is involved in the regulation of bufalin-induced apoptosis in human leukemia cellsOncogene, 1999
- Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cellsLeukemia Research, 1995
- Selective Inhibitory Effect of Bufalin on Growth of Human Tumor Cells in vitro: Association with the Induction of Apoptosis in Leukemia HL‐60 CellsJapanese Journal of Cancer Research, 1994
- Preclinical phase II studies in human tumor xenografts: A European multicenter follow-up studyAnnals of Oncology, 1994
- Pharmacology and toxicology of toad venomJournal of Pharmaceutical Sciences, 1967